No ke aha he mea nui ka Peptide ʻEwalu Koena ʻEuʻu no ka ʻimi ʻimi Metalloenzyme

Pane wikiwiki

An eight-residue peptide — Ac-VCTLCSCY — was synthesized from the conserved metal-binding motif of cobalt nitrile hydratase, loaded with one equivalent of Co(I…

ʻO ka pilikia Enzyme ka Peptide i hoʻolālā ʻia e kāpae

Acetyl Hexapeptide 1 Kūʻai nui Nā Punawai Peptide ʻO ka pūnaewele hoʻoikaika kino nitrile hydratase Co-type e paʻa i kahi Co-spin haʻahaʻa(III) i loko o kahi N2S3 hui mua: ʻelua amidate nitrogens mai ka iwi kuamoʻo a me ʻekolu sulfur i loaʻa mai i ka cysteine ​​i loko o ʻekolu mau mokuʻāina hoʻokahe like ʻole - he thiolate, he sulfinate a me ka sulfinate. ʻO ka 1.8 Å hana aniani o ka Pseudonocardia thermophila enzyme (PDB 1IRE) hoʻoholo i ka αCys111 ma ke ʻano he cysteine-sulfinic acid a me ka αCys113 ma ke ʻano he cysteine-sulfenic acid, ʻO ke ʻano like i ʻike ʻia ma ka enzyme hao.

No ke aha he mea nui ka Peptide ʻEwalu Koena ʻEuʻu no ka ʻimi ʻimi Metalloenzyme

ʻAʻole ka hele ʻana i laila he ʻanuʻu pelupe wale. Pono ka maturation i ka protein activator, a no ka PtUa noi ʻo NHase Zhou a me nā hoa hana i kahi mīkini hoʻololi α-subunit: hana mua ka apo-α2β2 tetramer, hoʻokahi α-subunit e hoʻopaʻa i ʻelua Co(II)-loaʻa nā proteins ε, Hoʻokomo ʻia ka cobalt a hoʻopaʻa ʻia nā metala me nā cysteine ​​equatorial, a ua hoʻololi ʻia nā α-subunits i kēia manawa i ka apo-tetramer. Hōʻike maopopo ka haʻawina ʻo Frontiers he liʻiliʻi ka ʻike e pili ana i ke ʻano o kēia ma ka pae atomika.

ʻO ia ka pilikia wehewehe. I ka holoenzyme, hoʻokomo metala, ʻokiʻoki ʻana i ka cysteine, hui pū ʻia nā subunit a me ke komo ʻana o ka mea hoʻāla ma kahi hoʻokahi i nā manawa overlapping. ʻAʻole hiki ke hāʻawi ʻia kahi hoʻololi spectroscopic i kahi laʻana enzyme oʻo i kekahi o ia mau kumu, no ka mea, ke holo nei na mea e ae. ʻO ka wehe ʻana i ka scaffold ʻaʻole ia e wehe i ka pili; Wehe ia i nā mea huikau e hiki ʻole ai ke heluhelu ʻia ka ʻōnaehana maoli i hoʻokahi loli i ka manawa.

No ke aha he mea nui ka Peptide ʻEwalu Koena ʻEuʻu no ka ʻimi ʻimi Metalloenzyme

He aha ka "Modeled On the Motif" i kuhikuhi maoli

ʻO ke kumu i mālama ʻia ʻo CXXCSCX, a ke haʻi ʻia nei ka haʻawina e like me nā mea āpau ma waena o NHases. ʻO ke kūkulu i loaʻa mai ka PtʻO ke kumu NHase ʻo Ac-VCTLCSCY: ewalu koena, molecular mass 933.13 A, me kahi hui acetyl ma ka N-terminus i hoʻohui ʻia e hoʻonui i ka solubility. Hāʻawi ʻia ka peptide ma ke ʻano he pauka lyophilized o >98.5% maʻemaʻe a hoʻohana ʻia e like me ka mea i hāʻawi ʻia.

Ke hana nei kēlā me kēia mea kūlana. Hoʻonohonoho ka ʻokoʻa cysteine ​​i kahi e noho ai nā thiolates e pili ana i kekahi a me ka metala. Noho ʻo Ser6 ma waena o ka coordinating cysteinees, a i loko o nā kumu hoʻohālike hoʻohālikelike i kona kaulahao ʻaoʻao hydrogen-boa e hoʻopaʻa ai i nā sulfur cysteine ​​ma o ʻelua mau wai poʻomanaʻo waho.. Aia ka tyrosine C-terminal i ka peptide hoʻokolohua akā ua ʻoki ʻia i kahi hui methyl i nā hiʻohiʻona DFT., e like me nā kaulahao ʻaoʻao noncoordinating o Val, Thr a me Leu; ua hoʻohālike ʻia ka acetyl N-terminal me he formyl. Kokoke nā ʻātoma iwi kuamoʻo a me nā kaulahao ʻaoʻao o Cys2, Cys5, Ua mālama ʻia ʻo Ser6 a me Cys7.

ʻO ka palena ʻoiaʻiʻo o ke kūkulu ʻana he maʻalahi. ʻAʻole paʻa kahi peptide ʻewalu koena i ka buffer hoʻokahi geometry hoʻonohonoho; he mau laʻana, ʻo ia ke kumu e hōʻike ai ka spectrum EPR i ʻelua mau ʻāpana wili ma mua o hoʻokahi. Ua ʻoki ʻia a hoʻopau ʻia nā ʻano hoʻohālike me kahi continuum polarized (e = 80.4) me ʻelua mau wai ʻokoʻa - kahi lapaʻau kūpono, akā ʻaʻole ka peptide piha.

ʻO ka hopena kiko'ī pololei. Ua waiho ʻia kahi pāpale acetyl, he koena i paniia, a i ʻole kahi kumu cysteine ​​i scrambled e hoʻololi i ka hoʻonohonoho ligand. ʻAʻohe hiʻohiʻona hiʻohiʻona e hoʻihoʻi i ka hoʻokolohua i manaʻo ʻia mai kahi peptide me ka hoʻonohonoho ligand hewa; e hōʻike wale ʻo ia i kahi mole mole like ʻole me ka nui like.

No ke aha he ʻano hoʻohālike hiki ke mālama ʻia kahi peptide pōkole, ʻAʻole kahi Enzyme maʻalahi

He haiki ka ninau a na mea kakau: Loaʻa i ka NHase metala hoʻopaʻa ʻia ka ʻike kemika lawa e hoʻopaʻa ai iā Co(II) a e hoʻololi i ke kikowaena metala a me ka peptide ma hope o ka ʻike ʻana i ka dioxygen? He nīnau kēlā e pili ana i kahi kaʻina, a ʻo ke kaʻina ka mea e hāʻawi ai kahi peptide synthetic me ke koena o ka protein.

Ua hoʻohana ʻia ka paepae like ma waena o nā metala. Hoʻopili ka peptide like i kahi Fe kiʻekiʻe-spin(II) kikowaena anaerobic, a ʻo ka ʻike ʻana i ka O₂ e hoʻopuka mua i kahi wili waena (S = 3/2) ʻO Fe(III) kikowaena e hoʻololi ana i ka Fe milo haʻahaʻa(III) e like me ka equatorial cysteinees oxidize. ʻO kahi kūkulu hiki ke hoʻouka ʻia me ka hao a laila me ka cobalt, a heluhelu ʻia e nā spectroskopi like, he moena hoʻāʻo hiki ke hoʻohana hou ʻia ma mua o ka mole hoʻokahi.

ʻO ka hoʻohālikelike waho kokoke loa ʻo ka SODA peptide (ACDLPCG), he ʻehiku koena mai ka nickel superoxide dismutase. In Broering a me ke aʻo ʻana o nā hoa hana, Co-SODA oxidized i ʻelua mau ʻanuʻu hiki ke hoʻoholo: i loko o kekona, ua noho ka metala i ka paramagnetic (Co²⁺) ʻoiai ua hōʻike ka sulfur K-edge XAS i hoʻokahi thiolate i hoʻololi ʻia i sulfinate; ma luna o nā hola, ua hōʻike ʻo Co K-edge XAS i ka metala e hele ana i Co³⁺. ʻAʻole i oxidize ka lua o ka thiolate a ʻaʻole i hoʻokumu ʻia kahi paʻakikī catalytically active - pili i ka nele o ka axial thiolate.. He peptide ʻokoʻa kēlā me kahi kaʻina oxidation ʻē aʻe, a ʻaʻole pono e hoʻohui ʻia me nā hopena Ac-VCTLCSCY; ʻO kona waiwai ma ʻaneʻi he kumu ia no ka mea hiki a hiki ʻole i ka metallopeptide ke hoʻoholo.

Hāʻawi ka puke loiloi i ka counterweight. ʻO ka loiloi a Shalev no ka metal-peptide NMR ʻike ʻia he maʻalahi nā peptides e hoʻohālikelike i nā geometries hewa i ka wā o ka helu ʻana, ka hana ʻana i nā hopena hoʻolālā hewa, a hiki ke hoʻopaʻa ʻia nā kumu hoʻohālike i loaʻa mai i ka peptide me ka pili haʻahaʻa no ka mea ʻaʻole mālama ʻia nā ʻāpana paʻa a pau.. ʻAʻole kēlā he hoʻopaʻapaʻa kūʻē i ke ala; ʻo ia ke kumu e heluhelu pū ʻia ai nā kumu hoʻohālikelike a me nā spectroskopi lehulehu. He kükohu i hewa i ka wehewehe, ʻO ke ala hiki ke haʻi iā ʻoe ma mua o kahi holoenzyme kūpono no nā kumu ʻaʻole hiki i kekahi ke hoʻokaʻawale.

He aha ka Cobalt i hana maoli ai: ʻO ka hui ʻana a me nā mokuʻāina Spin

Ma lalo o nā kūlana anaerobic, ʻo ke kikoo UV-ʻike ʻia o ka Co(II)Ua hōʻike ka paʻakikī peptide i nā kaula hoʻoili hoʻoili ligand-to-metal 305 nm (e = 2800 M⁻¹cm⁻¹) a 355 nm (e = 2180 M⁻¹cm⁻¹), hāʻawi ʻia iā cysteine ​​thiolate-to-Co(II) hoʻoili kālā. No ka mea, hoʻohālikelike nā haʻawina metallopeptide i kēlā me kēia thiolate-Co(II) ka pilina ma kahi o 900–1200 M⁻¹cm⁻¹, ua kūlike nā ikaika i ʻike ʻia me nā thiolates paʻa ʻelua, ka waiho ʻana i ke kolu o ka cysteine ​​me ka nāwaliwali a i ʻole ka hui ʻana. ʻO nā kaula ligand-field nāwaliwali ma kahi kokoke 615, 685 a 735 nm (ε ≈ 300–400 M⁻¹cm⁻¹) ʻoi aku ka nui o ka ikaika ma mua o ka octahedral Co(II) hāʻawi maʻamau, e kuhikuhi ana i ka helu hoʻohui ʻehā a ʻelima paha.

Hoʻopili i ka apo-peptide me Co(II) ʻoiai ka nānā ʻana i ka absorbance ma ~ 685 nm kūpono ma kahi o hoʻokahi kahua paʻa no ka peptide, me ka mea maopopo Kd,app o 0.45 µM. Hōʻike maopopo nā mea kākau i ka mea e hiki ai i kēlā helu ke lawe: no ka mea, ua ʻoi aku ka nui o ka peptide ma mua o ka waiwai kūpono, hoʻopaʻa paʻa ka titration, e pili ana i ka stoichiometric hoʻopaʻa ʻana akā ʻaʻole i hoʻoholo ikaika i kahi sub-micromolar dissociation mau.. Hoʻohālikelike ʻia ka waiwai i nā mea i hōʻike ʻia no ka Co-NiSOD a me Co-SODA peptide complexes.

X-band EPR ma 12 Ua hoʻoholo ʻo K i ʻelua hōʻailona. ʻO ka mea mua he wahi liʻiliʻi rhombic low-spin Co(II) hiʻona me g-waiwai o 2.30, 2.25 a 2.03; L-band EPR ma 1.3 Ua hāʻule ʻo GHz i ka g-e hoʻoikaika i ka hoʻoholo I = 7/2 ʻoi aku ka maopopo o ka hoʻolālā hyperfine. ʻO ka lua, he hōʻailona kiʻekiʻe-spin haʻahaʻa haʻahaʻa ma waena 1,000 a 2,000 G me nā wahi huli hoʻoholo i g′ = 5.7 a 4.8, kulike me ka S = 3/2 ʻōnaehana. Hāʻawi ka hoʻohui ʻana i ka ikaika pili like no nā mea ʻelua ma lalo o nā kūlana anaerobic.

Ua makemake ʻo DFT i kahi geometry tetrahedral N2S2 no nā ʻano kiʻekiʻe-spin a me kahi ʻelima-coordinate., hoʻoheheʻe ʻia i nā ʻano ʻano huinahā-pyramidal no nā ʻano ʻano milo haʻahaʻa, me ʻeono mau hiʻohiʻona i hana ʻia ma nā kūlana kūpono ʻekolu o ka CysSH kūʻokoʻa (Cys2, Cys5 a i ʻole Cys7). Hoʻopili ʻia g-nā waiwai no nā kumu hoʻohālike ʻelima (1.98–2.57) hāʻule i ka ʻaelike kūpono me ka laulā hoʻokolohua 2.03–2.40, a ʻo ke kŘkohu me ka thiol neutral ma Cys7 i hoʻopuka hou i ke ʻano axial o ka hoʻokolohua g-ʻoi aku ka maikaʻi o ka tensor. ʻO ka wehewehe ʻana a nā mea kākau - he nui nā geometries coordination i loaʻa i loko o kahi scaffold maʻalahi - he wehewehe i kākoʻo ʻia e ka helu a me ka spectroscopy hui., ʻaʻole he hale i ana ʻia.

ʻOke ʻana: Ua Hoololi, Ka mea i manaoia, a me ka mea i hooholo ole ia

ʻO ka hōʻike ʻana i ka dioxygen i hoʻopau i ka Co(II) Hōʻike wikiwiki ka EPR, me ka loli ʻole o ka oxygen i nā ʻāpana o ke kiʻekiʻe- a me nā ʻano wili haʻahaʻa hiki ke helu ʻia ma mua o ka pau ʻana o nā hōʻailona. ʻO kahi hoʻohālikelike me Co(II) ma buffer i hoʻokumu i nā mea ʻelua: ʻokoʻa ka hōʻailona wili kiʻekiʻe mai ka aqueous cobalt mai ka hōʻailona ma ka paʻakikī, a ʻaʻole i hoʻokuʻu wale ka ʻike ʻana i ka ea i ka cobalt mai ka peptide. Ua kūlike ka nalowale o ka hōʻailona me ka oxidation i kahi EPR-silent low-spin Co(III), a ua hoʻololi like ke kikoo UV-ʻike ʻia - nā hoʻololi d-d ma waena 600 a 750 ua emi a nalowale ʻo nm i ka wā i ʻike ʻia ai nā pūʻulu hou ma kahi o 350, 465 a 620 nm, hiʻona o thiolate-to-Co(III) hoʻoili kālā.

Ma ka ʻaoʻao peptide, Ua hōʻike ʻo q-TOF LC-MS i nā hōʻailona kūlike me ka hoʻohui ʻana o ʻekolu mau oxygen atom ma hope o ka hoʻolaha ʻana o ka ea. Ua hoʻonui ʻia nā ʻano oxygenated i ka ikaika pili ma 10 a 15 h, a kiekie ae-m/z pili paha nā piko i ka hoʻohui wai. Kūlike nā hoʻololi me ka cysteine ​​​​oxidation i ka sulfenic a me ka sulfinic acid derivatives, nā hoʻololi like i loaʻa ma ka paena hana maoli.

ʻElua mau mea i hoʻokumu ʻole ʻia e ka ʻikepili, a pela ka pepa. ʻAʻole hoʻokumu pololei ka spectrometry i ke kūlana okisedia o ke kikowaena metala. A ʻaʻole hiki ke hoʻokumu ʻia ke kauoha o ka metala a me ka ligand oxidation mai ka ʻikepili i kēia manawa - hōʻike nā hopena i nā hana ʻelua i ka wā e hoʻopili ai me ka dioxygen., ʻaʻole ka mea e hele mua.

He mea nui nā mana e like me ka hopena. ʻAʻole waihoʻoluʻu ka hopena peptide-wale i ka ʻike ʻana i ka ea akā ua hoʻoholo ʻia, ma muli paha o ka hoʻokumu ʻana o disulfide. Ua ʻike ʻia nā ʻano mea oxygen liʻiliʻi me ka ʻole o ka cobalt, kūlike me ka haʻahaʻa haʻahaʻa cysteine ​​​​oxidation i ka wā o ka lawe ʻana i ka laʻana. ʻO ia ka hōʻike ponoʻī o ke aʻo ʻana e manaʻo ʻia kahi kumu oxidation baseline ma mua o ka hypothetical.

Hāpai pū nā mea kākau i kahi makaʻala i mua: ʻO ka hoʻolāʻihi ʻia ʻana o ka oxygen hiki ke hoʻohua i nā ʻano mea i hoʻoheheʻe ʻia, hiki ke komo i kahi kaiapuni bis-sulfinic-acid e like me ka overoxidized, NHase hana ole. No kēlā me kēia e hoʻolōʻihi i ka manawa incubation, he wanana ia e hoao ai, ʻaʻole kahi hopena paʻa.

Hōʻoiaʻiʻo Analytical: ʻO ka ʻenehana e pane i ka nīnau

ʻO kēlā me kēia ʻenehana i kēia haʻawina e pane i hoʻokahi nīnau a makapō i ka Nā Peptides Lepili nā mea ʻē aʻe. ʻO ka heluhelu ʻana i kahi pepa metallopeptide ʻo ia ka ʻike ʻana i ka mea.

Hiki ke hoʻopaʻa ʻia ka thiolate i ka metala a ʻehia paha., ma o ka LMCT band ikaika e kū'ē i ka ~900–1200 M⁻¹cm⁻¹ per-thiolate benchmark. ʻAʻole hiki iā ia ke hoʻonā i ke kūlana spin a i ʻole geometry, ʻaʻole hiki iā ia ke haʻi iā ʻoe i ka cysteine ​​i hoʻopaʻa ʻia.

E pane ana ʻo MCD a me EPR i nā mokuʻāina spin i loaʻa a i ka hapa hea; Ua hāʻawi ka ikaika EPR hoʻohui i ka ratio like kiʻekiʻe/haʻahaʻa-wili, a ua hōʻoia ka ʻōlelo hoʻonā L-band i ka haʻahaʻa haʻahaʻa ma o ka hyperfine structure. Akā makapō ʻo EPR iā EPR-silent Co(III), no laila ua kūlike ka nalowale o ka hōʻailona me ka oxidation me ka ʻole o ke ana pololei ʻana.

Pane ʻo LC–MS i ka nui o nā oxygen ma ka peptide a pehea e holomua ai me ka manawa. ʻAʻohe ʻōlelo e pili ana i ka sulfur e lawe ai iā lākou, ʻaʻohe mea e pili ana i ke kūlana oxidation o ka metala. Ua kākau maikaʻi ʻia nā palena maʻamau o ka oxidative-modification mass spectrometry - nā kaʻina hana hoʻololi e hoʻomaopopo i ka hāʻawi ʻana i kahi hoʻololi i kahi koena kikoʻī e koi pinepine i ka wehewehe MS/MS, a ʻo ka hoʻohālikelike ʻana i nā ʻano mea i hoʻopaʻa ʻia a me nā ʻano mea ʻole i hoʻoheheʻe ʻia mai nā chromatograms ion i unuhi ʻia e manaʻo i ka ionization like a me ka maikaʻi o ka hoʻouna ʻana..

Pane ʻo DFT i nā kumu hoʻohālike i hoʻohālikelike ʻia me ka geometrically a me ka ikaika, akā no nā hiʻohiʻona i ʻoki ʻia i helu maoli ʻia - ʻaʻole no ka peptide piha i ka hopena.

Ma ka ʻaoʻao synthesis, He mea aʻo nā loiloi hoʻokuʻu ponoʻī o ka haʻawina: noa thiols i ka 0.76 Ua hōʻoia ʻia ka mM apo-peptide stock e ka hoʻāʻo a Ellman, a me ka mola absorptivity ma 280 nm (1,096 M⁻¹cm⁻¹) ua hoʻokumu ʻia mai kahi pihi maʻamau i ʻike ʻia ka ʻike ma mua o ka manaʻo. ʻAʻole hoʻi he ʻenehana hōʻike metalloprotein, a ʻo nā mea ʻelua nā mea e pono ai no ka mea hoʻokahi.

ʻO ke kānāwai kūpono: ʻaʻole lawa ka ʻenehana hoʻokahi ma kēia papa inoa. ʻO kahi hōʻike kikoʻī e hāʻawi ana i hoʻokahi wale nō ʻaʻole i ʻike i kahi metallopeptide.

Maemae, ʻIkepili, ʻEhā mau nīnau like ʻole ka maʻiʻo a me ke kūlana oxidation

Hiki i kahi laʻana 98% maʻemaʻe e HPLC a hiki ʻole ke hoʻohana ʻia no kahi Co(II) hoʻokolohua. Palmitoyl Pentapeptide-4 Hoʻopau ka paradox i ka wā e kaʻawale ai nā nīnau ʻehā.

ʻO ka maʻemaʻe ka pākēneka o ka ʻāpana e ka HPLC. Ua ʻōlelo ʻo ia i ka nui o ka mea e hoʻoheheʻe ʻia e UV e like me ka piko nui. ʻAʻole ʻōlelo ʻia he aha kēlā piko, ʻAʻole ia e hoʻokaʻawale i kahi cysteine ​​i hoʻemi ʻia mai ka mea i hoʻokahe ʻia inā e hui pū ʻia nā mea ʻelua..

ʻO ka ʻike he hōʻoia orthogonal. Eia ke ʻano o ka spectrometry nuipa, a ʻo ka LC-MS ponoʻī o ka haʻawina e hōʻike ana i ke kumu o ka palena o ke ana nuipa hoʻokahi: i ka manawa e hoʻonui ai ka oxygen i ka nuipaʻa 16 No ka oxygen, hiki ke huikau ka peptide oxidized a me ka peptide ʻokoʻa ke ʻole i lawa ka hoʻonā nui a me ka pōʻaiapili chromatographic..

Maʻiʻo, aiʻole ka peptide net, ʻO ke kaulike nui - peptide me ka counterion, ka wai a me ka paʻakai. He mea nui ia maanei no ka mea, pili ka stoichiometry o ka titration i ka ʻike i ka nui o ka peptide i loko o ka cuvette.. Hiki ke hoʻopau ʻia ka manaʻo nominal i helu ʻia mai ka pauka i kaupaona ʻia me ka ʻole o ka hoʻoholo ʻana i ka ʻike e hiki ke hoʻololi i kahi pihi paʻa kūpono..

ʻO ke kūlana oxidation kahi waiwai o nā cysteine ​​a me ka metala ʻaʻole i hōʻike maʻemaʻe ʻia ka HPLC a i ʻole ka nuipaʻa paʻa.. He pauda lyophilized ia 98% maʻemaʻe e HPLC hiki ke loaʻa i kahi hapa koʻikoʻi o nā cysteine ​​i hoʻoheheʻe ʻia i nā ʻano sulfenic a i ʻole disulfide mai ka lawelawe ʻana a me ka lyophilization.. E hōʻike ʻia ma ke ʻano he nui iki aʻe, he manawa paʻa i hoʻololi ʻia, a i ʻole kahi titer free-thiol i hōʻemi ʻia e Ellman's. ʻO ka nānā ʻana o ke aʻo ʻana i nā ʻano oxygenated liʻiliʻi i ka nele o ka cobalt, pili i ka laʻana hana, ʻo ia ka hōʻike ʻana he ʻoiaʻiʻo kēia kāʻei kua.

Mamuli o ka rula hooholo: no ka oxidation-sensitive metallopeptide hana, e kuhikuhi i ka maʻiʻo free-thiol a me ka ʻike hoʻokahe e like me nā pae hoʻokuʻu, ʻAʻole wale ka maʻemaʻe HPLC a me ka nānā nui. ʻO nā loina analytical ma hope o ia mau kikoʻī e like me nā mea i waiho ʻia i loko I Q2(R2), nāna e mālama i ka ʻike, maʻemaʻe a me ka hoʻāʻo ʻana ma ke ʻano he ʻano hana ʻokoʻa ma mua o nā mea hoʻololi.

Ka Hana Metala a me ka Oxygen-Sensitive Workflow

He kiko'ī ka mea i hōʻike ʻia e ka haʻawina a pono e kope pololei. Ua hoʻomākaukau ʻia nā laʻana peptide a pau ma lalo o nā kūlana anaerobic i loko o kahi pahu mīkina lima palupalu Coy. Ua hoʻoheheʻe ʻia ka peptide i ka degassed 10 mM N-ethyl morpholine (AOLE) pale i ka pH 8.0, hāʻawi i kahi kala ʻole 0.76 mM apo-peptide stock i hoʻoheheʻe ʻia a hoʻopaʻa ʻia no nā thiols manuahi e ka hoʻāʻo a Ellman. Hoʻokahi mea like me CoCl₂·6H₂O, hoʻoheheʻe ʻia i loko o ka pahu hoʻokahi ma ka pH like, ua hoʻohui ʻia i ka peptide buffered.

ʻO nā mea e pili ana mai ka kemika hoʻonohonoho ʻana ma mua o ka pepa e pono e haʻi ʻia ma ke ʻano he kumu hoʻolālā. ʻO ke kauoha o ka hoʻohui a me ka ratio metala-i-peptide e hoʻoholo inā i manaʻo ʻia 1:1 nā ʻano paʻakikī a i ʻole ka hui ʻana; ʻo ia ke kumu i holo ai ka titration ma mua o ka manaʻo. He mea koʻikoʻi ke koho ʻana no ka hoʻokūkū ʻana i nā mea pale no ka metala, a ua koho ʻia ʻo NEM ma ke ʻano he morpholine buffer non-coordinating. A ʻo ka peptide-wale nō ka ua ma ka ʻike ʻana i ka ea, ʻo ia hoʻi ka hoʻokumu ʻana o disulfide he ala hoʻokūkū e hoʻoneʻe i ka peptide mai ka hopena ma mua o ka hiki ke hoʻopaʻa i ka cobalt - kahi ala pohō e hoʻohālikelike ʻia me ka manawa lawelawe.. ʻO ka polypeptide pancreatic

ʻO ke āpau pololei: ʻAʻole hōʻike ka pepa i ka hoʻoponopono ʻōnaehana o ka ratio metala, ka hoʻohui ʻana a i ʻole ka ʻike pale. ʻO ka mea heluhelu e hoʻonui ana i kēia ke hoʻonui i ke ʻano, ʻaʻole kope, a pono e mālama i kēlā me kēia o ia mau ʻano he mea e hōʻoia ai i loko o kā lākou ʻōnaehana ponoʻī ma mua o kahi koi āpau.

He aha ka R&Pono ʻo D Lead e nīnau ma mua o ka hoʻouna ʻana i kahi Metallopeptide Sensitive Oxidation

ʻO nā nīnau ma lalo nei nā mea e hoʻoholo inā kākoʻo kahi metallopeptide i kūʻai ʻia i ka hoʻokolohua. Hiki ke pane ʻia kēlā me kēia ma kahi kamaʻilio kikoʻī.

Kaʻina a me ka mana. ʻO ke kaʻina pololei - me ka acetyl N-terminal a me nā koena maʻamau ʻole - i hoʻopaʻa ʻia ma ke ʻano he moʻolelo hoʻokele mana., a ke hōʻike nei ka palapala hōʻoia? ʻO ka hoʻoponopono kaʻina me ka ʻole o ke ala immutable version ke kumu maʻamau o kahi hoʻokolohua metallopeptide non-reproducible..

ʻO ke kūlana cysteine. He aha ka maʻiʻo free-thiol i ka hoʻokuʻu ʻana, ma ke ala hea, a ʻo nā ʻano mea hoʻoneʻe i hōʻike ʻia ma ke ʻano he palena? ʻO kēia ka nīnau no ka nānā ʻana i ka hoʻopaʻa ʻana-oxidation ponoʻī i hiki ʻole ke kūkākūkā. Mea Hana Acetyl Hexapeptide-1

ʻIkepili. Aia ka hōʻoia orthogonal ma mua o ke ana nuipa hoʻokahi, a ke hoʻoholo nei ka nuipa spectrometry i nā hoʻohui oxygen? He ala hiki ʻole ke hoʻokaʻawale +16 ʻAʻole hiki i ka makua ke hōʻike i kahi moʻolelo oxidation.

Maʻiʻo. Ua hōʻike kaʻawale ʻia ka ʻike peptide net mai ka maʻemaʻe HPLC, a ua ʻōlelo ʻia ke ʻano counterion? ʻO Stoichiometry i ka titration paʻa e pili ana i ka mua; Hiki ke hilinaʻi ke ʻano buffer a me ka hoʻokūkū metala ma ka lua.

Ka lawelawe ʻana. Hāʻawi ʻia ka mea i loko o kahi ʻano a me ka puʻupuʻu e kākoʻo ana i ka hana hou anaerobic, a ke ʻōlelo nei ka palapala? He mea maʻalahi ka pauka lyophilized, akā ʻo ka hana hoʻoponopono kahi e komo ai ka oxygen.

Pūʻolo kālailai. Hāʻawi ʻia nā chromatograms maka a me nā kikoʻī me nā mea ʻike kumu - kolamu, gradient, lōʻihi nalu, ka laulā nui - ma mua o ka papa hōʻuluʻulu? ʻAʻole hiki ke nānā hou ʻia ka papa hōʻuluʻulu inā ʻike hewa ka hopena.

Kaulike. Inā puka ke kumu hoʻohālike mai nā milligrams a i nā pūʻulu nui, aia kahi kumu i ʻōlelo ʻia no ka manaʻo e paʻa ka ʻaoʻao oxidation? ʻO nā kaʻina oxidation-sensitive kahi i hōʻike mua ʻia ai nā loli kaʻina.

ʻAʻole hiki i kahi mea hoʻolako ke pane i ka nīnau cysteine-status ke haʻi nei iā ʻoe i kekahi mea e pili ana i ka hiki ke hoʻāʻo ma hope o ka palapala hōʻoia.. ʻO ia ka pane ʻike hoʻokahi ma ka papa inoa.

Kahi i ku ai ke kumu hoohalike

ʻAʻole ka peptide ka enzyme. Ua nele i ka β-subunit, ka activator protein, ka lua o ka hui hui a me ka subunit-swapping maturation alahele. ʻO ka hoʻohālikelike ʻana o ke aʻo ʻana i ka ʻōnaehana maoli ma ke ʻano hoʻohālikelike o ka mokuʻāina spin a me ka hoʻololi ligand, ʻaʻole ma ka hana catalytic - ʻaʻole i ana ʻia ka wai nitrile ma ʻaneʻi.

ʻAʻole i hoʻoholo ʻia ke kauoha o ka metala versus ligand oxidation i kēia ʻōnaehana, e like me ka olelo a ka poe kakau. ʻO ka hoʻopaʻa mau ʻana he waiwai ʻike ʻia i ana ʻia ma lalo o nā kūlana i ʻae ʻole i ka hoʻoholo sub-micromolar koʻikoʻi.. Hoʻopau ʻia nā hiʻohiʻona DFT a hoʻopau ʻia. A ʻo ke kemika hoʻonanea i ʻike ʻia, ʻo ia ka mea e hiki mai ana i kahi kumu hoʻokaʻawale i loko o ka buffer - kahi ʻōlelo e pili ana i ka hoʻoulu ʻana o ke kumu., ʻaʻole he koi e pili ana i ke kaʻina o ka maturation intracellular.

ʻAʻohe o kēia e hoʻonāwaliwali i ka hopena. Hōʻike ia i ka mea e kākoʻo ai ka hopena: ʻo ke kaʻina mālama wale nō e lawe i ka ʻike kemika e hoʻopaʻa ai iā Co(II) a e hoʻopili i ka metala a me ka cysteine ​​​​oxidation ma ka hoʻolaha ʻana i ka dioxygen.

Ka hopena

He mea nui ka peptide ʻewalu koena no ka mea e hoʻohuli ʻo ia i kahi nīnau maturation intractable i loko o kahi hoʻonohonoho o nā mea hoʻololi hiki ke ana - helu hoʻonohonoho., kūlana milo, helu oxygen, kūlana free-thiol - kēlā me kēia me kahi ʻenehana e hōʻike ana iā ia a me kahi wahi makapō i kākau ʻia. ʻO ka ʻike ʻana ʻo ka motif mālama ʻia wale nō e hoʻopaʻa iā Co(II) a e hoʻopili ʻia me ka metala a me ka cysteine ​​​​oxidation ma ka ʻike ʻana i ka ea he ʻōlelo e pili ana i ka ʻike kemika intrinsic o ke kaʻina..

He mea hilinaʻi wale nō e like me ke kaʻina o ka hāpana, kūlana oxidation a me nā palapala analytical. No nā hui e kūkulu ana i kēia ʻano hoʻohālike, ʻO ka hana aʻe he kamaʻilio kikoʻī ma mua o kahi kauoha kūʻai: e wehewehe i ka maʻiʻo free-thiol, palena hoʻohāhā, net peptide content a me ka pūʻolo ʻikepili maka ma mua o ka hana ʻana i ka milligram mua. MOL Changes hoʻolako i nā peptides maʻamau me ka palapala HPLC a me MS, koho koho peptide maʻiʻo hoʻoholo a me ka counterion kālailai, a me ka lawelawe anaerobic-like ma ke noi; pili kēlā mau mana i nā nīnau kikoʻī ma luna, a pono ka poʻe heluhelu e noʻonoʻo i kēlā hoihoi pāʻoihana i ka loiloi ʻana i ke alakaʻi koho koho.

ʻO MOL Changes kahi ʻepekema peptide R&D hui a hāʻawi i nā peptides maʻamau a me nā lawelawe hoʻāʻo analytical. Pono ka poʻe heluhelu e noʻonoʻo i kēia makemake pāʻoihana i ka wā e loiloi ai i ke alakaʻi koho koho i kēia ʻatikala.

Kumu kumu: ʻO ka haʻawina kobalt metallopeptide kumu.

Bingyan Gao

Bingyan Gao

Mea Hana Pono a me Analytical Kaʻike kumu: ʻO ka hoʻokaʻawale ʻana a me ka ʻike ʻana i nā ʻano haumia, Hoʻomohala ʻano hana HPLC/MS, ka hoʻomaʻemaʻe kiral, a me ka hoʻokō ʻana i nā pharmacopoeias honua.

Pilikino: ʻO Bingyan Gao ka "puka kiaʻi hope" o ka maʻemaʻe peptide a me ka maikaʻi. Maikaʻi ʻo ia i ka hoʻohana ʻana i nā mea analytical kiʻekiʻe kiʻekiʻe a loea i ka hoʻomohala ʻana i nā ʻano hoʻokaʻawale chromatographic maʻamau no nā peptides hoʻololi paʻakikī.. Ua hoʻokumu ʻo ia i kahi ʻōnaehana hoʻomaʻemaʻe pono ʻole e hōʻoia i ka maʻemaʻe o ka huahana 99% a i ʻole kiʻekiʻe aʻe akā ʻike pono a hoʻopau i nā ʻano haumia i hiki ke hoʻoulu i ka immunogenicity. Me ka hoʻomaopopo hohonu ʻana i nā koi hoʻoponopono FDA a me EMA no nā lāʻau peptide, hōʻoia ʻo ia ʻo kēlā me kēia pūʻulu i hoʻokuʻu ʻia mai ka hale hana e hele pū ʻia me kahi palapala hōʻoia o ka ʻike ʻana (COA).

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana